
Sleep loss might be an early warning of Alzheimer's disease according to a recent research at Washington University School of Medicine.
Sleep is affected in patients suffering from Alzheimer's disease. The findings of the latest research suggest that sleep problems could as well be markers for the initiation of the disease.
Advertisement
Previous experiments on mice have revealed that a link exists between sleep loss and beta amyloid plaques in the brain, which is a significant marker for the disease.
The study involved healthy 145 participants aged between 45 and 75 years who showed no signs of Alzheimer's disease when enrolled.
Scientists analyzed the spinal fluids of the participants and the samples 32 of them were found to have molecular markers for preclinical Alzheimer's disease.
The sleep cycles of the volunteers were also recorded for two weeks and it was found that those without markers of the disease slept well when compared to those with the markers.
Hence, the authors opine that loss of sleep could be used as an indicator to the onset of Alzheimer's disease in elderly people.
Source: Medindia
Scientists analyzed the spinal fluids of the participants and the samples 32 of them were found to have molecular markers for preclinical Alzheimer's disease.
Advertisement
The sleep cycles of the volunteers were also recorded for two weeks and it was found that those without markers of the disease slept well when compared to those with the markers.
Hence, the authors opine that loss of sleep could be used as an indicator to the onset of Alzheimer's disease in elderly people.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News

Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.

By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.

Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.

Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.

Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.